levallorphan has been researched along with n-methyllevallorphan in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno, L; Fioramonti, J; Lopez, Y | 1 |
| Douglas, H; Kitchen, I | 1 |
| Jiang, Q; Porreca, F; Sheldon, RJ | 1 |
| Inoki, R; Kudo, T; Ohkubo, T; Shibata, M; Takahashi, H | 1 |
| Hedler, L; Schurr, C; Starke, K; Szabo, B | 1 |
| Appelmans, N; Bianchetti, A; Dragonetti, M; Ferrarese, N; Giudice, A; Manara, L; Simon, EJ; Tarantino, A | 1 |
| Colombo, M; La Regina, A; Petrillo, P; Sbacchi, M; Tavani, A | 1 |
| Calcagnetti, DJ; Fanselow, MS; Helmstetter, FJ | 1 |
| Bianchetti, A; Guidice, A; Manara, L; Nava, F | 1 |
| Bueno, L; Fargeas, MJ; Fioramonti, J | 1 |
| Bianchetti, A; Cattaneo, C; Dragonetti, M; Ferrarese, N; Giudice, A; Manara, L; Sacilotto, R | 1 |
| Akers, RM; Barnes, MA; Johnson, DW; Pearson, RE | 1 |
| Bruins, AP; de Jonge, K; de Zeeuw, RA; Drenth, BF; Ensing, K; Lanting, AB; Meijer, DK | 1 |
13 other study(ies) available for levallorphan and n-methyllevallorphan
| Article | Year |
|---|---|
Central and peripheral control of postprandial pyloric motility by endogenous opiates and cholecystokinin in dogs.
Topics: Animals; Benzodiazepinones; Central Nervous System; Cholecystokinin; Dietary Fats; Dogs; Eating; Endorphins; Gastric Emptying; Levallorphan; Naloxone; Peripheral Nerves; Pylorus | 1991 |
Non-opioid effects of N-methyl levallorphan in the anaesthetised rat.
Topics: Acetylcholine; Anesthesia; Animals; Dimethylphenylpiperazinium Iodide; Enkephalin, Methionine; Ganglionic Blockers; Half-Life; Hemodynamics; Hexamethonium Compounds; Levallorphan; Male; Nitroprusside; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Opioid; Urethane | 1990 |
Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
Topics: Analgesics; Animals; Body Fluids; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Injections, Intraperitoneal; Intestinal Mucosa; Intestines; Levallorphan; Male; Mice; Mice, Inbred ICR; Receptors, Opioid | 1990 |
[Peripheral analgesic actions of opioid peptides and morphine analogues].
Topics: Analgesics, Opioid; Animals; Cyclazocine; Dynorphins; Enkephalin, Methionine; Ethylketocyclazocine; Levallorphan; Lidocaine; Male; Mice; Morphine; Naloxone; Pain; Peptide Fragments | 1986 |
Peripheral sympatho-inhibitory cardiovascular effects of opioid peptides in anaesthetized rabbits.
Topics: Animals; Decerebrate State; Dynorphins; Electric Stimulation; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Hemodynamics; Levallorphan; Male; Naloxone; Norepinephrine; Pentobarbital; Quaternary Ammonium Compounds; Rabbits; Sympathetic Nervous System | 1988 |
Relative affinities of the quaternary narcotic antagonist, N-methyl levallorphan (SR 58002), for different types of opioid receptors.
Topics: Animals; Binding, Competitive; Cerebellum; Guinea Pigs; Ileum; In Vitro Techniques; Levallorphan; Male; Narcotics; Rabbits; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vas Deferens | 1985 |
Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
Topics: Animals; Behavior, Animal; Brain; Buprenorphine; Gastrointestinal Motility; Intestine, Small; Levallorphan; Male; Morphine; Muscle, Smooth; Naloxone; Nociceptors; Rats | 1988 |
Central and peripheral injection of quaternary antagonist, SR58002C, reduces drinking.
Topics: Animals; Dose-Response Relationship, Drug; Drinking Behavior; Female; Injections, Intraperitoneal; Injections, Intraventricular; Levallorphan; Rats | 1987 |
Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.
Topics: Animals; Body Weight; Diarrhea; Levallorphan; Mice; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1986 |
Different targets for i.v. vs. i.c.v. administered morphine for its effect on colonic motility in dogs.
Topics: Animals; Colon; Dogs; Gastrointestinal Motility; Injections, Intravenous; Injections, Intraventricular; Levallorphan; Morphine; Naloxone; Narcotic Antagonists | 1985 |
Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
Topics: Animals; Constipation; Female; Gastrointestinal Motility; Levallorphan; Mice; Morphine; Naloxone; Structure-Activity Relationship | 1983 |
A synthetic opioid peptide increases plasma growth hormone and prolactin in Holstein calves.
Topics: Animals; Blood-Brain Barrier; Cattle; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Female; Growth Hormone; Injections, Intravenous; Least-Squares Analysis; Levallorphan; Naloxone; Narcotic Antagonists; Prolactin; Random Allocation | 1993 |
Identification with liquid chromatography-ionspray mass spectrometry of the metabolites of the enantiomers N-methyl dextrorphan and N-methyl levorphanol after rat liver perfusion.
Topics: Animals; Bile; Chromatography, Liquid; Dextrorphan; In Vitro Techniques; Levallorphan; Liver; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Conformation; Perfusion; Rats; Rats, Wistar; Stereoisomerism | 1993 |